Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypoxia

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Influence of airway pressure and fibrosis on lung surface shear wave elastography.

Journal of medical ultrasonics (2001)·2026

Same author

Advances in redox imaging for cancer diagnosis and therapy.

Journal of clinical biochemistry and nutrition·2026

Same author

Electron paramagnetic resonance imaging to detect acute kidney injury.

American journal of physiology. Renal physiology·2025

Same author

Synthesis and preclinical evaluation of a <sup>68</sup>Ga-labeled peptide for PET imaging of transferrin receptor 1 in tumor.

European journal of nuclear medicine and molecular imaging·2025

Same author

Enhancement of radio-sensitivity by inhibition of Janus kinase signaling with oclacitinib in canine tumor cell lines.

Molecular therapy. Oncology·2025

Same author

Low Field Magnetic Resonance Imaging to Detect Acute Kidney Injury.

bioRxiv : the preprint server for biology·2025

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

Imaging cycling tumor hypoxia.

Shingo Matsumoto¹, Hironobu Yasui, James B Mitchell

¹Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-1002, USA.

Cancer Research

|December 17, 2010

Summary

This summary is machine-generated.

Cycling hypoxia, characterized by oxygen fluctuations in tumors, enhances cancer cell survival and treatment resistance. Electron paramagnetic resonance imaging (EPRI) can noninvasively map these hypoxic regions for better treatment planning.

More Related Videos

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Related Experiment Videos

Last Updated: Jun 6, 2026

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Area of Science:

Oncology
Medical Imaging
Biophysics

Background:

Cycling hypoxia is a recognized phenomenon in solid tumors, characterized by fluctuating oxygen levels (pO(2)).
These fluctuations can occur distant from microvessels, sometimes near normal tissue, with varying frequencies.
Cycling hypoxia promotes tumor cell survival pathways and resistance to therapies like radiation and chemotherapy.

Purpose of the Study:

To investigate the potential of Electron Paramagnetic Resonance Imaging (EPRI) for characterizing cycling hypoxia in tumors.
To assess EPRI's capability in mapping tumor oxygenation dynamics and informing treatment strategies.

Main Methods:

Utilized Electron Paramagnetic Resonance Imaging (EPRI) for noninvasive spatial and temporal mapping of tumor pO(2).
Distinguished between chronic and cycling hypoxic regions using EPRI.
Applied EPRI in animal models with implanted or orthotopic tumors.

Main Results:

EPRI demonstrated the ability to differentiate chronic and cycling hypoxic tumor regions.
EPRI provided quantitative maps of tumor pO(2) with necessary spatial and temporal resolution.
The technique allows for longitudinal examination of tumor pO(2) in response to treatment.

Conclusions:

EPRI is a valuable tool for noninvasively imaging and quantifying cycling hypoxia in tumors.
Understanding cycling hypoxia dynamics through EPRI can aid in personalized treatment planning.
EPRI holds potential for future clinical applications in oncology.